Catalyst Wire Dossier Catalyst Wire Dossier

Ibuprofen Prolonged-Release 300 mg

ibuprofen · Reckitt Benckiser Healthcare (UK) Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ibuprofen Prolonged-Release 300 mg, covering 2024-06-03 to 2024-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of 300 mg Ibuprofen Prolonged-Release Tablets for the Treatment of Pain After Surgical Removal of Impacted Third Molars [Phase 3]

See pricing